Randolph Corteling | Chief Scientific Officer
ReNeuron

Randolph Corteling, Chief Scientific Officer, ReNeuron

Appearances:



Day 2: 18th March 2026 @ 13:35

Panel Discussion: Innovation In Gene Editing - Leveraging Platform Technology to Enhance Development Efficiency

last published: 15/Sep/25 15:35 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150